Thromb Haemost 1981; 45(02): 107-109
DOI: 10.1055/s-0038-1650144
Original Article
Schattauer GmbH Stuttgart

Plasmin Potency Estimates: Influence of the Substrate Used in Assay

Roger D Philo
The Division of Blood Products, National Institute for Biological Standards and Control, Hampstead, London, U. K.
,
Patrick J Gaffney
The Division of Blood Products, National Institute for Biological Standards and Control, Hampstead, London, U. K.
› Author Affiliations
Further Information

Publication History

Received 28 July 1980

Accepted 12 January 1981

Publication Date:
05 July 2018 (online)

Summary

A urokinase-activated plasmin (UK-plasmin) preparation was assayed against the International Reference Preparation for Plasmin (IRP-plasmin) using caseinolytic, fibrinolytic, fibrinogenolytic and chromogenic assay methods. The relative potency (using multi-dose bioassays) was estimated by the fibrinolytic method to be about twice that obtained by the caseinolytic, fibrinolytic and chromogenic assay methods. It was found that the UK-plasmin binds to fibrin to a greater extent than does the IRP-plasmin and this is advanced as an explanation for the discrepancy between assay methods. This difference in the binding of the two plasmins to fibrin may mean that it will be difficult to compare the fibrinolytic activities of various plasmin preparations.

It is also shown that, during thermal degradation, the IRP-plasmin loses fibrinolytic activity more rapidly than amidolytic activity.

 
  • References

  • 1 Christensen LR, McLeod MC. A proteolytic enzyme of serum. Characterization, activation with inhibitors. J Gen Physiol 1945; 28: 559-583
  • 2 Remmert LF, Cohen P. Partial purification and properties of a proteolytic enzyme of human serum. J Biol Chem 1949; 181: 431-448
  • 3 Derechin M. The assay of human plasminogen with casein as substrate. Biochem J 1961; 79: 443-449
  • 4 Johnson AJ, Kline DL, Alkjaersig N. Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems. Thromb Diath Haemorrh 1969; 21: 259-272
  • 5 Permin PM. Properties of fibrinokinase fibrinolysin system. Nature 1947; 160: 571-572
  • 6 Fletcher AP. The measurement of the compopents of the plasminogen-plasmin system in biological fluids. Biochem J 1954; 56: 677-682
  • 7 Wolf P. Modification of the fibrin agar plate for measurement of the components of fibrinolytic system. Thromb Diath Haemorrh 1968; 20: 50-77
  • 8 Bishop R, Ekert Fr, Gilchrist G, Schanbrom E, Fekete L. The preparation and evaluation of a standardized fibrin plate for the assessment of fibrinolytic activity. Thromb Diath Haemorrh 1970; 23: 202-210
  • 9 Marsh NA, Arocha-Pinango CL. Evaluation of the fibrin plate method of estimating plasminogen activators. Thromb Diath Haemorrh 1972; 28: 75-88
  • 10 Kanai S, Okamoto H, Tamaura Y, Yamazaki S, Inada Y. Fibrin suspension as a substrate for plasm: determination and kinetics. Thromb Haemostas 1979; 42: 1153-1158
  • 11 Vukovich Th. Quantitative determination of plasmin: a fibrinogenolytic method. Clin Chim Acta 1977; 79: 285-290
  • 12 Troll W, Sherry S, Wachman J. The action of plasmin on synthetic substrates. J Biol Chem 1954; 208: 85-93
  • 13 Roberts PS. Measurement of rate of plasmin action on synthetic substrates. J Biol Chem 1958; 232: 285-291
  • 14 Lassen M. The esterase activity of the fibrinolytic system. Biochem J 1958; 69: 360-366
  • 15 Friberger P, Knӧs M, Gustavsson S, Aurell L, Claeson G. Methods for the determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251. Haemostasis 1978; 7: 138-145
  • 16 Gaffney PJ, Lord K, Brasher M, Kirkwood TBL. Problems in the assay of thrombin using synthetic peptides as substrates. Thromb Res 1977; 10: 549-556
  • 17 Gaffney PJ, Miller-Andersson M, Kirkwood TB L. Unreliability of chromogenic substrates for assay of thrombin clotting activity. Haemostasis 1978; 7: 109-112
  • 18 Kirkwood TB L, Campbell PJ, Gaffney PJ. A standard for human plasmin. Thromb Diath Haemorrh 1975; 34: 20-31
  • 19 Campbell PJ. International biological standards and reference preparations. I: Preparation and presentation of materials to serve as standards and reference preparations. J Biol Stand 1974; 2: 249-258
  • 20 Ploug J, Kjeldgaard NO. Urokinase: an activator of plasminogen from human urine. Biochim Biophys Acta 1957; 24: 278-282
  • 21 Markus G, Depasquale JL, Wissler FC. Quantitative determination of the binding of ɛ-aminocaproic acid to native plasminogen. J Biol Chem 1978; 253: 727-732
  • 22 Wiman B, Wallen P. The specific interaction between plasminogen and fibrin. A physiological role of the lysine binding site in plasminogen. Thromb Res 1977; 10: 213-222
  • 23 Sottrup-Jensen L, Claeys M, Zajdel M, Petersen TE, Magnusson S. The primary structure of human plasminogen: isolation of two lysine binding fragments and one “mini”-plasminogen (MW, 38.000) by elastase-catalysed-specific limited proteolysis.. In: Progress in Chemical Fibrinolysis and Thrombolysis. Davidson JF, Rowan RM, Samama MM, and Desnoyers PC. eds 03. Raven Press; New York: 1978. pp 191-209
  • 24 Gaffney PJ. A critical evaluation of chromogenic substrates in standardisation.. In: Chromogenic Peptide Substrates: Chemistry and Clinical Usage. Scully MF, and Kakkar VV. eds Churchill Livingstone: Edinburgh: 1979. pp 42-49
  • 25 Kornalik F, Blombäck B. Prothrombin activation induced by – a prothrombin converting enzyme from Echis carinatus venom. Thromb Res 1975; 6: 53-63
  • 26 Lämmle B, Duckert F. Different assessment of plasmin with different substrates. In vitro alteration of plasmin, influence of epsilonaminocaproic acid and tranexamic acid upon its activities. Thromb Haemostas 1980; 43: 112-117